ArticleCardio-oncology (London, England)2017

Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development.

Daniel Pinkhas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.